Chemosensitive outcome, stratified by sAAIPI
. | . | . | . | Response* to ICE chemotherapy . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|
sAAIPI risk group (no. factors) . | . | PFS at 4 y† . | OS at 4 y‡ . | CR . | . | PR . | . | |||
. | N . | % . | % . | N . | % . | N . | % . | |||
Low (0) | 18 | 69 | 83 | 12 | 67 | 6 | 33 | |||
Intermediate (1) | 34 | 46 | 55 | 11 | 32 | 23 | 68 | |||
High (2,3) | 56 | 25 | 26 | 19 | 34 | 37 | 66 |
. | . | . | . | Response* to ICE chemotherapy . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|---|
sAAIPI risk group (no. factors) . | . | PFS at 4 y† . | OS at 4 y‡ . | CR . | . | PR . | . | |||
. | N . | % . | % . | N . | % . | N . | % . | |||
Low (0) | 18 | 69 | 83 | 12 | 67 | 6 | 33 | |||
Intermediate (1) | 34 | 46 | 55 | 11 | 32 | 23 | 68 | |||
High (2,3) | 56 | 25 | 26 | 19 | 34 | 37 | 66 |